By comparison, six billion-dollar-plus deals were inked during ... It’s not just the first quarter, either. Big-ticket biotech buyouts have been getting scarcer for months now.

U.S. stocks jumped in a widespread rally Tuesday, and other U.S. investments steadied a day after falling sharply on worries about President Donald Trump’s trade war and his attacks on the head of the ...